YI
111, Inc.
YI · NASDAQ
$3.60 +1.41% (+$0.05)
1M +2.91%
Market Cap ¥204.2M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$5.3
47.2% upside
Current Price
$3.6
Undervalued Fair Value Overvalued
According to Bulios Fair Price, YI is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/S 0.02x
P/E N/A
EV/EBITDA N/A
Growth
3 /100
Declining Rev. growth 3.32%
EPS growth N/A
FCF growth N/A
Profitability
1 /100
Weak Gross margin 5.74%
Net margin 0.66%
Op. margin 0.24%
Quality
21 /100
Poor ROIC 38.99%
ROA 26.90%
Asset turnover 40.46x
Debt
18 /100
High Current ratio 1.08x
Int. coverage -0.49x
Debt/Equity N/A
Stability
62 /100
Moderate Beta 0.65x
Rev. volatility 12.91%
EPS volatility 46.12%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about YI
Online
Sector
Healthcare
Industry
Medical - Distribution
CEO
Junling Liu
Employees
1,063
Headquarters
Shanghai
Upcoming events
26 NOV
Earnings
Upcoming earnings report